Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ramucirumab in Indian Patients with Advanced Gastric Cancer-Does Borderline Performance Status and Heavy Burden of Disease in Real World Practice Impact Clinical Benefit?
Ramaswamy A, Bajaj K, Talwar V, Prabhash K, Batra U, Dhabhar B, Sharma M, Ghadyalpatil N, Ct S, Goyal G, Muzamil J, Bhatt A, Jain P, Ranade A, Kamath M, Gawande JP, Thippeswamy R, Mirani J, Reddy N, Ganguly S, Mishra SK, Madabhavi I, Hp S, Panda SS, Patil S, Bhargava P, Ostwal V. Ramaswamy A, et al. Among authors: thippeswamy r. South Asian J Cancer. 2021 Sep 4;11(1):24-30. doi: 10.1055/s-0041-1728980. eCollection 2022 Jan. South Asian J Cancer. 2021. PMID: 35833042 Free PMC article.
Stage IV lung cancer: Is cure possible?
Thippeswamy R, Noronha V, Krishna V, Joshi A, Bal MM, Purandare N, Rangarajan V, Pramesh CS, Jiwnani S, Prabhash K. Thippeswamy R, et al. Indian J Med Paediatr Oncol. 2013 Apr;34(2):121-5. doi: 10.4103/0971-5851.116207. Indian J Med Paediatr Oncol. 2013. PMID: 24049303 Free PMC article.
Practice patterns and outcomes with the use of regorafenib in metastatic colorectal cancer: Results from the Regorafenib in Metastatic colorectal cancer - An Indian exploratory analysis study.
Ramaswamy A, Ostwal V, Pande N, Sharma A, Patil S, Thippeswamy R, Ghadyalpatil N, Roy R, Peshwe H, Poladia B, Rajamanickam D, Rangarajan B, Neelesh Reddy PR, Pandita V, Mukherjee A, Thoke A, Sarkar A, Satish CT, Shashidara H, Banavali SD. Ramaswamy A, et al. Among authors: thippeswamy r. South Asian J Cancer. 2019 Jan-Mar;8(1):22-26. doi: 10.4103/sajc.sajc_173_18. South Asian J Cancer. 2019. PMID: 30766846 Free PMC article.
Real world study of safety and efficacy of lorlatinib as second line and beyond in ALK-rearranged advanced non-small cell lung cancer patients in India - a multicentre chart review study (ROSELAND).
Biswas B, Ghadyalpatil NS, Patil S, Patel A, Ganguly S, Rathore A, Guleria B, Tarannum CF, Ghosh J, Kondapally MS, Thippeswamy R, Reddy SHP, Roy S. Biswas B, et al. Among authors: thippeswamy r. Ecancermedicalscience. 2024 Feb 13;18:1667. doi: 10.3332/ecancer.2024.1667. eCollection 2024. Ecancermedicalscience. 2024. PMID: 38439810 Free PMC article.
Lomustine, cytarabine, cyclophosphamide, etoposide - An effective conditioning regimen in autologous hematopoietic stem cell transplant for primary refractory or relapsed lymphoma: Analysis of toxicity, long-term outcome, and prognostic factors.
Gupta A, Gokarn A, Rajamanickam D, Punatar S, Thippeswamy R, Mathew L, Bagal B, Kannan S, Khattry N. Gupta A, et al. Among authors: thippeswamy r. J Cancer Res Ther. 2018 Jul-Sep;14(5):926-933. doi: 10.4103/0973-1482.181183. J Cancer Res Ther. 2018. PMID: 30197327 Free article.
14 results